Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diagnostics
    • Rapid, automated...

    Rapid, automated molecular test for better diagnosis of tuberculosis in children

    Written by Medha Baranwal Baranwal Published On 2019-10-28T19:05:29+05:30  |  Updated On 28 Oct 2019 7:05 PM IST
    Rapid, automated molecular test for better diagnosis of tuberculosis in children

    China: Rapid, automated molecular test-Xpert Mycobacterium tuberculosis and rifampicin (MTB/RIF) Ultra assay has a better performance than traditional bacteriologic and other molecular tests for the diagnosis of tuberculosis in children, a recent study published in the AAP journal Pediatrics has found.


    Ultra assay is a rapid, automated molecular test for tuberculosis developed by Cepheid (Sunnyvale, USA). According to WHO, ultra cartridge include a larger chamber for DNA amplification (ie. a larger amount of sputum is used for amplification and detection of DNA) and two additional molecular targets to detect TB. Owing to this, the assay shows increased sensitivity, has improved the ability of the assay to detect low numbers of bacilli.


    According to WHO estimates, an estimated 1 million children became ill with TB and 233 000 children died of TB in 2017. However, the actual burden of TB in children is likely higher given the challenge in diagnosing childhood TB.


    Ultra assay has increasingly been used in adult tuberculosis diagnosis, but data relating to its diagnostic accuracy in children are lacking. A qualified sputum specimen is difficult to obtain in children. Lin Sun, Capital Medical University, Beijing, China, and colleagues evaluated the diagnostic value of Ultra in childhood tuberculosis using bronchoalveolar lavage fluid in this study.


    For the purpose, the researchers enrolled 93 children with pulmonary tuberculosis and 128 children with respiratory tract infections. The accuracy of Ultra was calculated by using bacteriologic results and clinical evidence as reference standards.


    Key findings include:

    • The sensitivity of Ultra, in all pulmonary tuberculosis cases and in bacteriologically confirmed tuberculosis cases, was 70% and 91%, respectively.

    • Ultra could detect Mycobacterium tuberculosis in 58% of cases with negative culture or acid-fast–staining results.

    • The specificity of Ultra was 98%.

    • There was no significant difference in sensitivity between samples with a volume ≤1 and >1 mL (66% vs 73%).

    • Among 164 children for which Ultra and Xpert were simultaneously performed, the sensitivity was 80% and 67%, respectively, indicating good agreement.

    • An additional 6 children were identified as Ultra-positive but Xpert-negative.

    • The positive rate decreased from 93% to 63% after 1 month and to 71% after 2 months of antituberculosis treatment.


    "Ultra using bronchoalveolar lavage fluid has good sensitivity compared with bacteriologic tests and adds clinical value by assisting the rapid and accurate diagnosis of pulmonary tuberculosis in children," concluded the authors.


    However, they also note that the current cost of the Ultra assay is a prohibitive factor in its implementation as a point-of-care test, especially in low-income countries where there is a high burden of tuberculosis. "To be financially viable in low-income countries, a large increase in tuberculosis funding and/or a further reduction in the price of the Ultra test would be needed," they write.


    More Information: "A Test for More Accurate Diagnosis of Pulmonary Tuberculosis" published in the Pediatrics journal.


    DOI: https://doi.org/10.1542/peds.2019-0262


    Journal Information: Pediatrics

    bronchoalveolar lavage fluidDiagnosisLin SunMedical newspediatric tuberculosisPediatrics journalrecent medical newssensitivityTuberculosisUltra assayXpert Mycobacterium tuberculosis and rifampicin ultra assay
    Source : Pediatrics�

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medha Baranwal Baranwal
    Medha Baranwal Baranwal
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok